Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer
Peter Zanvit(Early Intervention Foundation), Emily E. Bosco(Cincinnati Children's Hospital Medical Center)
Cited by 49
Related Papers
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
|Journal of Clinical Investigation|2006|192